Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
about
Understanding the population genetics of Plasmodium vivax is essential for malaria control and eliminationThe international limits and population at risk of Plasmodium vivax transmission in 2009Artemisinin combination therapy for vivax malariaKnowledge, attitudes and practice of communities of Wolaita, Southern Ethiopia about long-lasting insecticidal nets and evaluation of net fabric integrity and insecticidal activityPrimaquine in vivax malaria: an update and review on management issuesThe use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaIn vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central EthiopiaEfficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studiesEfficacy of Chloroquine for the Treatment of Vivax malaria in Northwest EthiopiaAnti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysisDihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trialMolecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of ChinaMonitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013.Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in EthiopiaReturn of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.School-based surveys of malaria in Oromia Regional State, Ethiopia: a rapid survey method for malaria in low transmission settings.In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.In silico studies on DARC.Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.Climatic variables and malaria transmission dynamics in Jimma town, South West Ethiopia.Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South EthiopiaPlasmodium vivax associated severe malaria complications among children in some malaria endemic areas of EthiopiaEfficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania.Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, IndonesiaMolecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in EthiopiaIn vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central ChinaLong-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol.Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulationsPolymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia.Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west EthiopiaVariation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern EthiopiaMolecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana Health Care Centre, southern EthiopiaChloroquine efficacy for Plasmodium vivax malaria treatment in southern EthiopiaAdvances in the treatment of malariaEfficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern SudanComparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.
P2860
Q17485678-E4A1D8E0-B059-474E-9C88-B7AE040022B4Q21144525-12C6200A-142D-4D0C-A761-33774E77DA1AQ24622539-9958D420-56F5-4C58-8512-CF6A1AEF494DQ26315527-CC60DE25-A2E9-4DEE-96A0-B59814330F6AQ27003856-110B79C3-5254-4A9F-A454-42A38986215BQ28478579-D8A431ED-27EA-4164-A334-D443B2BE7BB6Q28533253-E9C6144B-CFBC-494E-9D76-E3F4ADE645E2Q28535686-14E333BB-0827-4208-923A-B28C998AFAC1Q28553811-0A073113-5C79-4EDC-906E-60F7BD3EC1E2Q33869090-CA0C0448-336F-4192-9245-29A01E0EEF10Q34049080-25A91D83-70E5-48C2-B538-D71ADCB40C56Q34168392-30CE1589-49D7-4289-A9E8-9A702CA86936Q34269531-55A4636D-B2D0-403F-971F-62BA526FF003Q34422288-0074003A-53E3-4FA9-BA80-998866E9C978Q34504371-077AF850-3E79-47B4-848B-8EFA83B29D48Q34576847-E0725BC5-D2F1-4383-8F4C-75C39799222AQ34596770-9F798973-0B6B-4A9E-AB33-C0998AEDB8BBQ34646141-E1ADA73D-5390-454F-94A6-287FA090799CQ34658695-67324AA1-1281-4A5B-B442-933C4B71C3C4Q34660024-7D9900E7-CE6E-49F4-8BDF-77C4018279DCQ34662739-2DBA2BC7-8793-406F-9036-8B30F7686703Q34790356-A15469C0-18AF-42A5-96EC-3AE3891A6492Q34802650-D4F2B40D-CB5D-423F-B405-6E5976208003Q35052724-2C13A7E1-7F0A-41C3-98FF-9ADDF5A799A0Q35095652-F8A9872D-1BEF-4DE4-8320-C9232D956C69Q35122442-6A8339FB-FA4A-489A-98D4-0409D906E260Q35131344-3EB08DEE-87E4-4DD9-9AE7-E60F1C7D532CQ35191980-885A4407-0133-42E3-B2A1-EFD31F76A634Q35207264-6050BD68-C880-4FF9-8530-ADDF6ABA1251Q35497890-2FD0885F-DB84-4413-8FE2-C13BD9CAC02EQ35575316-BAA2A969-F903-4942-90F7-31E95B1D1C0AQ35807931-8AF42428-ADD5-4CB2-9328-98CF6281342CQ35814367-153C7B5F-A20C-49C4-8AEC-3496BC193FADQ36235143-48B6294B-77A3-41BE-9721-4B4BBA2CAB6FQ36294230-2ADE79A5-5729-45D8-8F35-6C5D91545C34Q36402050-B45F3DF9-EB66-4D4B-A954-CE19BFBB933DQ36404786-A3906AB2-8487-4A60-AB46-DF1B59B7A00EQ36459402-B66185CF-212C-4D31-9BBE-7C5DAE1363C7Q36507974-AA8D1AF3-D522-425E-95B3-EFD282233ED4Q36667032-F9945034-8906-4103-AB2D-4791EF921F3C
P2860
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
@en
type
label
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
@en
prefLabel
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
@en
P2093
P2860
P921
P356
P1433
P1476
Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia
@en
P2093
Beyene Petros
Gezahegn Tesfaye
Gilbert Kokwaro
Hiwot Teka
Howard Engers
Ibrahim Elhassan
Lawrence Yamuah
Simon Muchohi
P2860
P2888
P356
10.1186/1475-2875-7-220
P577
2008-10-29T00:00:00Z
P5875
P6179
1022870043